Patent 8709425 was granted and assigned to Biosceptre International Limited on April, 2014 by the United States Patent and Trademark Office.
The present invention provides antibodies that specifically bind to P2X7 receptors and distinguish between function and non-functional P2X7 receptors, pharmaceutical compositions and kits containing the antibodies, and methods of using the antibodies for the detection, diagnosis and treatment of disease conditions.